Pediatrix Medical Group, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Pediatrix Medical Group, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | $71.71M | Nov 3, 2025 |
| Q2 | 2025 | Jun 30, 2025 | $39.26M | Aug 5, 2025 |
| Q3 | 2025 | Jun 30, 2025 | $39.26M | Nov 3, 2025 |
| Q1 | 2025 | Mar 31, 2025 | $20.74M | May 6, 2025 |
| Q3 | 2025 | Mar 31, 2025 | $20.74M | Nov 3, 2025 |
| Q2 | 2025 | Mar 31, 2025 | $20.74M | Aug 5, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $19.44M | Nov 3, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($153.03M) | Aug 5, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($153.03M) | Nov 3, 2025 |
| Q1 | 2025 | Mar 31, 2024 | $4.04M | May 6, 2025 |
| Q3 | 2025 | Mar 31, 2024 | $4.04M | Nov 3, 2025 |
| Q2 | 2025 | Mar 31, 2024 | $4.04M | Aug 5, 2025 |
| Q3 | 2024 | Sep 30, 2023 | $21.39M | Nov 1, 2024 |
| Q2 | 2024 | Jun 30, 2023 | $28.28M | Aug 6, 2024 |
| Q3 | 2024 | Jun 30, 2023 | $28.28M | Nov 1, 2024 |
| Q1 | 2024 | Mar 31, 2023 | $14.21M | May 7, 2024 |
| Q3 | 2024 | Mar 31, 2023 | $14.21M | Nov 1, 2024 |
| Q2 | 2024 | Mar 31, 2023 | $14.21M | Aug 6, 2024 |
| Q3 | 2023 | Sep 30, 2022 | $30.73M | Nov 2, 2023 |
| Q3 | 2023 | Jun 30, 2022 | $27.14M | Nov 2, 2023 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | $68.05M | Nov 3, 2025 |
| Q2 | 2025 | Jun 30, 2025 | $59.87M | Aug 5, 2025 |
| Q1 | 2025 | Mar 31, 2025 | $32.10M | May 6, 2025 |
| Q3 | 2025 | Sep 30, 2024 | $33.83M | Nov 3, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($157.72M) | Aug 5, 2025 |
| Q1 | 2025 | Mar 31, 2024 | $15.89M | May 6, 2025 |
| Q3 | 2024 | Sep 30, 2023 | $40.27M | Nov 1, 2024 |
| Q2 | 2024 | Jun 30, 2023 | $48.50M | Aug 6, 2024 |
| Q1 | 2024 | Mar 31, 2023 | $30.04M | May 7, 2024 |
| Q3 | 2023 | Sep 30, 2022 | $47.39M | Nov 2, 2023 |
| Q2 | 2023 | Jun 30, 2022 | $50.16M | Aug 3, 2023 |
| Q1 | 2023 | Mar 31, 2022 | $39.11M | May 2, 2023 |
| Q3 | 2022 | Sep 30, 2021 | $58.79M | Nov 3, 2022 |
| Q2 | 2022 | Jun 30, 2021 | $50.02M | Aug 4, 2022 |
| Q1 | 2022 | Mar 31, 2021 | $26.10M | Apr 28, 2022 |
| Q3 | 2021 | Sep 30, 2020 | $20.46M | Oct 28, 2021 |
| Q2 | 2021 | Jun 30, 2020 | $34.57M | Aug 6, 2021 |
| Q1 | 2021 | Mar 31, 2020 | $10.80M | May 7, 2021 |
| Q3 | 2020 | Sep 30, 2019 | $48.57M | Nov 6, 2020 |
| Q2 | 2020 | Jun 30, 2019 | $59.39M | Jul 30, 2020 |